To assess whether DLG1 and CAP2 transcript alterations were selective for SCZ, we also measured their expression in the superior frontal gyrus of patients affected by neurodegenerative disorders, like Parkinson’s and Alzheimer’s disease. The gene discussed is DLG1; the disease is early-onset autosomal dominant Alzheimer disease.